标题
Impact of pioglitazone on bone mineral density and bone marrow fat content
作者
关键词
Bone Marrow Fat, Bone Mineral Density, Fracture, Pioglitazone
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 28, Issue 11, Pages 3261-3269
出版商
Springer Nature
发表日期
2017-07-22
DOI
10.1007/s00198-017-4164-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome
- (2015) Jeremy T. Warshauer et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
- (2015) Emma O. Billington et al. DIABETOLOGIA
- Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials
- (2014) Zhong-Ning Zhu et al. BONE
- Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis
- (2014) Toshio Takano et al. LABORATORY INVESTIGATION
- The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial
- (2013) Andrew Grey et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures
- (2013) Janina M Patsch et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus
- (2013) John P. Bilezikian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Marrow Fat and Bone—New Perspectives
- (2013) Pouneh K. Fazeli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Novel Adipokines and Bone Metabolism
- (2013) Yuan Liu et al. International Journal of Endocrinology
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
- (2012) H. M. Colhoun et al. DIABETOLOGIA
- Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial
- (2012) Andrew Grey et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Rosiglitazone and Pioglitazone Inhibit Estrogen Synthesis in Human Granulosa Cells by Interfering with Androgen Binding to Aromatase
- (2011) D. Seto-Young et al. HORMONE AND METABOLIC RESEARCH
- Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT
- (2011) Elaine W Yu et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Rosiglitazone Decreases Bone Mass and Bone Marrow Fat
- (2011) Torben Harsløf et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes
- (2011) Akihiro Kudoh et al. LIFE SCIENCES
- The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial
- (2010) Ugis Gruntmanis et al. CALCIFIED TISSUE INTERNATIONAL
- Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
- (2010) R. E. Aubert et al. DIABETES OBESITY & METABOLISM
- Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
- (2010) Jong Suk Park et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- Noninvasive Quantification of Pancreatic Fat in Humans
- (2009) Ildiko Lingvay et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reproducibility of MR perfusion and1H spectroscopy of bone marrow
- (2009) James F. Griffith et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Thiazolidinedione-induced skeletal fragility - mechanisms and implications
- (2008) Andrew Grey DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search